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Sexual Functioning in Breast Cancer Survivors 
 
Heidi M. King 
 
ABSTRACT 
 
Breast cancer diagnosis and treatment has been suggested to effect sexual functioning.  
Little is known about how breast cancer patients compare to women without a history of 
cancer on measures of sexual functioning, as well as the psychological and physical 
factors may contribute to these difficulties.  To address these issues, 71 breast cancer 
patients and 40 of their nominated friends were recruited and served as participants.  All 
women received and returned via the mail measures on general background information, 
depression, fatigue, marital satisfaction, body image, vaginal symptoms, and sexual 
functioning.  All the psychological and physical variables assessed correlated with a 
measure of overall sexual functioning in the expected directions.  With the exception of 
the physical variable of vaginal problems (p = .006), where the patient group reported 
more problems, the groups did not differ on any remaining physical or psychological 
variables.  On the overall measure of sexual functioning, no significant differences were 
found between the two groups.  Additional exploratory analyses in which only women 
treated with chemotherapy were compared to the non-cancer participants yield similar 
patterns of results.  In addition, there was no evidence of interactive effects of age and 
breast cancer status on sexual functioning.  These results suggest that sexual functioning 
in women treated for breast cancer is similar that of a non-cancer comparison with the 
exception of more menopausal symptoms.  Continued research and interventions towards 
addressing menopausal symptoms may lead to even improved sexual functioning among 
breast cancer patients. 
  
 
 
 
Chapter One 
 
Introduction 
 
Breast cancer is the most common type of cancer diagnosed in women after skin 
cancer.  According to the American Cancer Society (2005), 211, 240 new cases of breast 
cancer will be diagnosed in 2005.  The death rate for this same year will be 40,410.  The 
breast cancer death rate in the 1990s declined by the largest amount in over 65 years.  
This sharp decline is due to both improvements in early detection, as well as multi-modal 
treatment (e.g., surgery, radiation, chemotherapy, and hormonal therapy).  With 97% of 
all women diagnosed with early stage breast cancer (Stage I or II) surviving for at least 
five years, research is expanding to deal more with side effects and quality of life issues.  
Side effects from cancer treatment may include fatigue, nausea, hair loss, compromised 
immune function, cognitive impairment, memory problems, depression, and sexual 
problems.  Although many of these problems abate after the completion of active 
treatment, sexual problems appear to persist (Ganz, Schag, Lee, Polinsky, & Tan, 1992; 
Ganz et al., 1996; Ganz, 1997). 
The present study has two aims.  The first aim is to compare sexual functioning of 
women diagnosed and treated with early breast cancer to that of a comparison group of 
women of a similar age without a cancer history.  These women will be compared on the 
following components of sexual functioning:  interest, desire, arousal, frequency of 
orgasm, sexual satisfaction, sexual activity, satisfaction with sexual relationship, 
masturbation, and frequency of severe sexual problems.   The second aim is to examine 
demographic (age, race, educational status), physical (fatigue and vaginal dryness), 
psychological (depression and body image), and social factors (marital dissatisfaction) 
that may explain individual differences in sexual functioning.  This study will compare 
the two groups of women, those with a history of breast cancer and those without a 
cancer history, on the demographic, physical, psychological, and social factors.  
Depending on the results of these analyses, the study may examine potential mediators of 
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 differences in sexual functioning between women with and without a history of breast 
cancer.    
Considerable variability exists in the literature regarding the prevalence of sexual 
dysfunction in breast cancer survivors.  Fifteen to 37 percent of a sample of 218 women 
(Schover et al., 1995) with early stage breast cancer reported sexual dysfunction.  In 
contrast, Barni and Mondin (1997) reported that 96% of their sample were experiencing 
one or more sexual problems.     
Ganz et al. (1996) examined the occurrence of sexual functioning problems by 
assessing breast cancer survivors at one year post-diagnosis and again either two years 
(n=69) or three years post diagnosis  (n=70).   Women two or three years post-diagnosis 
were all experiencing significant worsening in the area of sexual functioning compared to 
their year one data (p=0.0001, p=0.0009, respectively).  These data suggest that sexual 
functioning may deteriorate over time among breast cancer survivors. 
Measurement Issues 
Inconsistent methodology employed in studies of sexual functioning of breast 
cancer survivors may account for the discrepant reports of problems.  Kiebert, de Haes, 
and van de Velde (1991) summarized some general methodological issues that plague 
quality of life research on breast cancer survivors.  These issues include inconsistencies 
with regard to samples studied (e.g., selection and size), types of treatment, evaluation 
points, and assessment tools.     
The selection of samples has varied in terms of different inclusion/exclusion 
criteria, as well as the means used to recruit survivors.  Disease stages included in studies 
of sexual functioning include women with stage 0 disease (Ganz et al., 1998) through 
stage III disease (Yurek, Farrer, & Andersen, 2000; Gilbar et al., 1997).  Also, the sample 
sizes across studies have varied from 24 women (Lim, Hoe, Wong, & Soo, 1995) to 
1,957 women (Ganz, Desmond, Belin, Meyerowitz, & Rowland, 1999).  Next, women 
have varied on the types of treatment they received.  Currently, a multi-modal approach 
to treatment is used including a combination of surgery, chemotherapy, radiation, and 
hormonal therapy.  
Another variation in studies is the point at which the participant is evaluated.  For 
example, Schover et al. (1995) collected surveys from 218 women who were anywhere 
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 between 0.4 to 9.5 years post surgery.  Along with the variability of time at which the 
participant is assessed, many studies also lack baseline data or a premorbid assessment of 
sexual functioning.  
Finally, assessment tools used in studies vary in their format, reliability, and 
validity.  The assessment of sexual functioning is complicated.  A broad range of facets 
combine to make-up this construct, and researchers do not always agree on these facets.  
Often times, researchers develop their own multiple-choice questions about sexual 
functioning (Schover et al., 1995).  
Ganz (1997) points out that sexual functioning in women with breast cancer must 
be studied in relation to sexual functioning in healthy women.  Breast cancer is primarily 
a disease of aging women.  Sexual functioning naturally declines with age.  Therefore, in 
order to accurately gauge the effects of breast cancer and its treatment on sexual 
functioning, one must compare women with breast cancer to healthy women without a 
history of breast cancer.  Although several studies have used normative data to interpret 
findings regarding sexual functioning (Mortimer et al., 1999; Ganz, Rowland, Desmond, 
Meyerowitz, & Wyatt, 1998), no other study was found that included a healthy 
comparison group.   
Relationship of Demographic Variables to Sexual Functioning 
There has been mixed evidence regarding the relationship of age to sexual 
functioning difficulties in breast cancer survivors.  Schover et al. (1995) examined the 
relationship of age to sexual functioning in 218 women who were between 0.4 and 9.5 
years post surgery for breast cancer.   Women in this study were a mean of 54.2 years old 
(SD = 11.8).  The authors found that expression of affection and overall sexual 
satisfaction did not differ statistically between younger (< 60 years) and older (> 60 
years) women.  In contrast, frequency of sexual activity (p<0.0001), as well as sexual 
desire (p<0.001), was higher among the younger women. 
Regarding differences in sexual functioning across ethnic/racial groups, most 
samples to date have consisted primarily of Caucasian women.  The numbers for minority 
women have typically been too small to be analyzed separately.  One exception to this 
pattern is a study by Ashing-Giwa (1999) that compared quality of life, including sexual 
functioning, in 117 African-American women and 161 Caucasian women who were 
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 diagnosed with breast cancer and were at least six years post-diagnosis.  Results indicated 
that the groups did not differ significantly on a sexual functioning subscale.  Scores on 
the sexual functioning subscale were higher than all other Cancer Rehabilitation and 
Evaluation Survey-Short Form (CARES-SF; Schag & Heinrich, 1989) scales suggesting 
that sexual functioning was a concern across ethnic groups. 
Relationship of Surgical Variables to Sexual Functioning 
The emergence of breast conserving surgery as a viable treatment option (Fisher, 
et al., 1985) led health care providers to believe that this less mutilating procedure would 
result in fewer sexual concerns (Ganz & Coscarelli, 1995).  Numerous studies have 
sought to evaluate this possibility.  Moyer (1997) performed a meta-analysis, based on 23 
studies involving 1,860 women of the effects of type of breast cancer surgery on marital-
sexual adjustment.  The outcome of marital-sexual adjustment reflects the inclusion of 
studies that assessed marital satisfaction and/or sexual functioning.  The meta-analysis 
revealed a small, but statistically significant weighted mean effect size (ES=0.093, 
p<0.05).  The effect size was in the positive direction indicating that women who had 
undergone lumpectomies generally reported better marital-sexual adjustment than women 
who had undergone mastectomies.   
Relation of Chemotherapy and Endocrine Therapy to Sexual Functioning 
 Numerous studies have been conducted to examine the impact of chemotherapy 
and/or endocrine therapy (tamoxifen) on sexual functioning in breast cancer patients.  
The following studies serve as examples of research that examined the sexual effects of 
chemotherapy, chemotherapy plus tamoxifen, or tamoxifen. 
Schover et al. (1995) looked at the influence of chemotherapy and tamoxifen use 
on sexual functioning.  When compared to a group of breast cancer survivors treated 
without chemotherapy (n=175), women treated with chemotherapy (n=43) were found to 
be experiencing significantly greater problems with desire (p=0.032), vaginal lubrication 
(p<0.0001), pain (p<0.001), and achieving orgasm during sexual intercourse (p=0.043).  
In addition, they reported significantly poorer sexual satisfaction (p=.001) and had sex 
less frequently (p=0.013).   
In the same study, Schover et al. (1995) found that women who received 
tamoxifen (n=44) did not differ significantly from women who did not receive tamoxifen 
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 (n=131) on the following sexual variables (after correcting for age and chemotherapy):  
frequency, desire, vaginal dryness, pain, ability to reach orgasm during sexual 
intercourse, or overall sexual satisfaction.   
Ganz et al. (1999) found history of chemotherapy to be a significant predictor of 
sexual dysfunction in two independent samples of early stage (0-II) breast cancer 
survivors who were between one and five years post-diagnosis (Ganz et al., 1999).  The 
two independent samples (n=863, n=1094) completed the following sexual functioning 
questionnaires:  the Breast Cancer Prevention Trial Symptom Checklist (BCPT; Ganz, et 
al, 1998), the CARES, the Watts Sexual Functioning Scale (WSFQ; Watts, 1982), and a 
one-item satisfaction measure.  Use of tamoxifen was not consistently associated with 
sexual interest, dysfunction, or satisfaction.  However, in the second sample use of 
tamoxifen was related to less sexual satisfaction. 
Ganz, Rowland, Myerowitz, and Desmond (1998) conducted further research on 
the second independent sample (1094 women from Los Angeles and Washington D.C.).  
These women had stage 0, I, or II disease and were one to five years post-diagnosis.  
They were broken up into the following four groups:  no adjuvant therapy (n=265), 
tamoxifen (n=356), chemotherapy (n=180), or chemotherapy plus tamoxifen (n=295).  
Controlling for age and time since diagnosis, sexual functioning was significantly related 
to type of therapy (p = 0.0078).  Women who received chemotherapy were more likely to 
report pain during intercourse (p=0.0076).  Overall, those women receiving 
chemotherapy (p=0.0096), as well as women receiving tamoxifen (p=0.034), reported 
more problems with sexual functioning than those women who received no adjuvant 
therapy.   
Relation of Physical Factors to Sexual Functioning  
 Few studies have investigated the relationship of menopausal symptoms (i.e., hot 
flashes, vaginal problems, and urinary problems) to sexual functioning in breast cancer 
patients (Ganz et al, 1999; Greendale, Lee, & Arriola, 1999).  An intervention study 
conducted by Ganz et al. (2000) compared symptomatic breast cancer patients who 
received education, skills, medications, and support targeted towards these symptoms (n= 
33) to a usual care group (n = 39).  Results indicated that both menopausal symptoms (p 
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 = .0004) and sexual functioning (p = .04) improved for those women involved in the 
intervention group relative to those receiving usual care. 
Relation of Psychological Factors to Sexual Functioning 
Numerous studies (Mock, 1993; Schover, 1995; Ganz et al., 1998; Ganz et al., 
1992) have investigated body image disturbance and depression in breast cancer 
survivors.  Although both these factors have been well studied in this population, only 
body image has been examined in relation to sexual functioning.   
Carver et al. (1998) studied concerns about body image and their relationship to 
sexual functioning in 66 women with early stage (I or II) breast cancer.  Sexual 
functioning was measured using items assessing attractiveness, sexual desirability, and 
frequency of sexual activity.  Results indicated that body image concerns were related to 
decreased feelings of sexual desirability.  Ganz et al. (1999) tested models for predicting 
sexual interest, sexual dysfunction, and sexual satisfaction using two samples of sexually 
active breast cancer survivors (n=472 and n=662, respectively) who were between 1.7 
and 4.3 years from diagnosis.  Body image was measured using the CARES Body Image 
Subscale.  Body image was found to account for significant variance in the sexual 
satisfaction in the first sample, but was not a significant predictor of sexual satisfaction in 
the second sample. 
Aims 
The current study has two aims.  The first aim is to determine whether breast 
cancer patients experience poorer sexual functioning than women of comparable age with 
no history of breast cancer.  This was undertaken in order to address a major limitation in 
the existing literature.  By including appropriate non-cancer comparison group, the nature 
and severity of problems in sexual functioning among breast cancer patients would be 
better identified. 
The second aim is to identify psychological and clinical variables that might 
mediate any observed relationship between breast cancer status (positive versus negative 
history of breast cancer) and sexual functioning.  Variables of interest included 
depression, fatigue, marital satisfaction, body image dissatisfaction, and vaginal dryness 
as these variables have been shown to differ, or might be expected to differ based on 
breast cancer status.  As a precondition to examining their role as mediators, it will first 
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 be necessary to test hypotheses that these variables: a) are associated with poorer sexual 
functioning in the sample as a whole and b) are related to breast cancer status (positive 
versus negative history of breast cancer). 
Hypotheses 
The first set of hypotheses posits that women diagnosed and treated for early 
stage breast cancer would report poorer sexual functioning in comparison to a 
comparison group of women of a similar age without a history of cancer.  Specifically, 
women with early stage cancer, when compared to a group of women of a similar age 
with no history of cancer, are expected to report:  
 1A.   Less sexual interest 
 1B.   Less sexual desire 
  1C.   Less sexual arousal 
  1D.   Less frequency of orgasm 
  1E.   Less sexual satisfaction 
  1F.   Less sexual activity 
  1G.  Less satisfaction with sexual relationship 
  1H. Less desire to and arousal from masturbation 
  1I.   More frequent and severe sexual problems. 
A second set of hypotheses posits that the following psychological and physical 
factors will be associated with poorer overall sexual functioning in the sample as a whole: 
 2A.   Higher levels of fatigue 
 2B.   Greater symptoms of depression 
 2C.   Greater marital dissatisfaction 
 2D.   Poorer body image 
 2E.   Greater vaginal dryness  
A third set of hypotheses posits that, compared to a comparison group of women 
of similar age with no history of cancer, women diagnosed and treated for early stage 
breast cancer will report: 
 3A.   Higher levels of fatigue 
 3B.   Greater symptoms of depression 
 3C.   Greater marital dissatisfaction 
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  3D.   Poorer body image 
 3E.   Greater vaginal dryness. 
 Depending on results of hypothesis testing, exploratory analyses would be 
undertaken to determine the extent to which differences in fatigue, depression, marital 
satisfaction, body image, and vaginal dryness mediate any discovered relationship 
between history of breast cancer and poorer sexual functioning.   
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Chapter 2 
 
Method 
Participants 
  Patients.  Breast cancer patients treated at the H. Lee Moffitt Cancer in the past 
five years were identified via the Moffitt registry.  Information regarding date of 
diagnosis, stage, and type of treatment received were obtained from the registry.    In 
addition to being diagnosed with early stage breast cancer (stage 0, I, or II), these women 
met the following eligibility criteria:  1) at least 18 years of age, 2) proficient in English, 
3) able to provide informed consent, 4) no psychiatric or medical conditions that would 
hinder participation, 5) medical visit in the last year that confirmed no clinical evidence 
of breast cancer, 6) at least one year and no more than five years post diagnosis, 7) no 
other cancer history (with the exception of basal skin cancer ), and 8) have a spouse or 
romantic partner.  These women were asked to complete a questionnaire through the mail 
inquiring about their level of fatigue, mood, marital satisfaction, body image, and sexual 
health.  In addition, these women were asked to provide contact information for female 
friends within fifteen years of their age who had never been diagnosed with breast cancer 
who may be willing to serve as members of a non-cancer comparison sample.   
Of the 563 MCC patients who received initial letters about the study, 230 (41%) 
were unable to be contacted (see Figure 1). Of the patients contacted, 83 (25%) were 
found to be ineligible.  From the remaining women contacted 179 (72%) refused thus 
leaving 71 (28%) analyzable questionnaires. The mean age of these women was 61 years  
(SD = 9.87, range = 39 to 82 years).  The majority were Caucasian (96%), married 
(93%), had greater than a high school education (80%), were employed outside the home 
(56%), had an annual household income greater than $40,000 (72%), and were 
postmenopausal (96%) (see Table 1).  Medically, the majority of women were diagnosed 
with Stage I (41%) and Stage II (45%) disease, were treated surgically with 
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 lumpectomies (84%), received radiation treatment only (53%), and were between 3 and 5 
years post-diagnosis (83%) (see Table 2).  
Non-Cancer Comparison Group. Using peer nomination procedures, a sample of 
women without a history of breast cancer was also obtained for the study.  In addition to 
having no prior cancer diagnoses (with the exception of basal skin cancer), the nominated 
group also met the following eligibility criteria:  1) at least 18 years of age, 2) proficient 
in English, 3) informed consent, 4) no psychiatric or medical conditions that would 
hinder participation, and 5) have a spouse or romantic partner.      
Of the 123 women nominated, 22 (18%) were unable to be contacted (see Figure 
2).  Of those contacted, 18 (18%) were found to be ineligible.  From the remaining 
women contacted, 34 (41%) refused to participate thereby leaving 49 questionnaires 
(59%).  Upon determining that the non-cancer comparison group had over-sampled 
women in the fifth decade relative to the patient group, an approximate 2-to-1 matching 
procedure by decade of age was used that resulted in exclusion of nine women from the 
non-cancer comparison group. Thus, the final non-cancer comparison group was 
comprised of 40 women.  The mean age of these women was 60 years (SD = 9.83, range 
39-82).  The majority were Caucasian (100%), married (90%), had higher than a high 
school education (90%), were not employed outside the home (62%), and had a 
household income of greater than $40,000.00 (65%).   Eighty percent of the women 
reported being postmenopausal (see Table 1). 
Procedure 
 An introductory letter (see Appendix A) was sent to breast cancer patients from 
the Moffitt registry selected randomly after stratifying by time since diagnosis and 
treatment received.  A toll-free number was included in the letter that allowed the 
recipient to decline any further information about the study.  Breast cancer patients were 
then contacted by telephone and read a scripted description (see Appendix B) of the 
study, were asked questions to confirm eligibility, and were asked whether they were 
willing to provide verbal consent for participation.  Upon receiving verbal consent, each 
patient received the following materials through the mail:  two copies of the written 
informed consent, two copies of the HIPPA research form, a questionnaire packet, a peer 
nomination form, personalized nomination cards, and a self-addressed stamped envelope.  
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 Each participant was asked to return one signed copy of the informed consent and HIPPA 
research authorization form, a completed packet, a completed peer nomination form, and 
completed personalized nomination cards.  The personalized nomination cards had a 
preprinted summary of the study on a Moffitt card leaving the salutation and closing 
blank so the participant could personalize the card to the person they were nominating.  
All nomination cards were returned to the researcher so that they could be tracked.   
 Initially, breast cancer participants were asked to nominate peers without a history 
of breast cancer who were anywhere from five years younger to five years older than 
themselves.  However, due to difficulties recruiting, the age range was increased on May 
19, 2004 to fifteen years younger to fifteen years older than the breast cancer participants.   
 Women who were nominated received the invitation (see Appendix C) 
personalized by the breast cancer patient who nominated her.  This card was followed-up 
with a phone call and scripted description of the study, interest was established, and 
eligibility confirmed.  Upon receiving verbal consent, each woman received the 
following materials through the mail:  two copies of the written informed consent, two 
copies of the HIPPA research authorization form, a questionnaire packet, a peer 
nomination form, personalized nomination cards, and a self-addressed stamped envelope.  
Each participant was asked to return one signed copy of the informed consent and HIPPA 
research authorization form, and a completed packet.    
Follow-up calls and letters were sent out to women who returned packets with 
missing information.  Thank you letters were sent out to all participants.  If requested, a 
pamphlet entitled, Sexuality and Cancer, sponsored by the American Cancer Society 
(2001) was provided.   
Measures 
The survey battery included measures of demographic and clinical information, 
along with valid and reliable measures of fatigue, depression, marital satisfaction, body 
image, symptom concerns, and sexual functioning.  The packet was estimated to take 
approximately 25 minutes to complete. 
Demographic and Clinical Information.  A standardized self-report measure was 
used to obtain general demographic and clinical information (see Appendix D and E).  
The following demographic information was obtained:  age, ethnicity, marital and 
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 employment status, income, occupation, and educational level.  General medical and 
sexual history information was also obtained from all participants.  Medical history 
included menopausal status, use of hormone replacement therapy, and height and weight.  
Sexual history included questions about length of time with current sexual partner, as 
well as history of sexual problems for self or partner.  Participants with a history of breast 
cancer were asked additional questions specific to cancer diagnosis and treatment.  The 
information obtained included the time since diagnosis, type of surgery, and type of 
cancer treatment.  In addition to participant self-report, the H. Lee Moffitt Cancer 
Registry, as well as the participant’s medical charts were reviewed to obtain relevant 
medical history such as date of diagnosis, disease stage, type of cancer treatments, and 
history of cancer recurrences.  
Depressive Symptomatology.  The Center for Epidemiologic Studies, Depression 
Scale (CES-D; Radloff, 1977) is a 20-item self-report measure originally developed to 
assess current depressive symptomatology in the general population (see Appendix F).  
The following six components of depression are measured on 4-point Likert scales 
ranging from 1 (rarely or none of the time) to 4 (most or all of the time):  depressed 
mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness, 
psychomotor retardation, loss of appetite, and sleep disturbance.  Participants are asked to 
respond to each item based on the degree to which she has been experiencing each 
symptom for the past week.  Scores range from 0 to 60 with higher scores indicating 
more severe depressive symptomatology.  The CES-D is a reliable and valid measure.  
High internal consistency has been determined with split-half correlations for psychiatric 
patient groups (0.85), as well as normal groups (0.77) and with coefficient alphas for 
patient groups (0.90) and normal groups (0.85), respectively.  Coefficients alphas 
calculated in present study for the breast cancer patients (.89) and non-cancer 
comparisons (.91) reflect high internal consistency.   The CES-D has been shown to be a 
valid measure with its correlation to other depression inventories such as the Beck 
Depression Inventory (0.81), as well as the Zung Depression Scale (0.90) (Weissman, 
Prusoff, & Newberry, 1975).  Although validated in many different samples, it has been 
specifically shown to be psychometrically sound for assessing depressive symptoms in 
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 cancer patients (Devins, Orme, Costello, & Binik, 1988; Hann, Winter, & Jacobsen, 
1999).    
Fatigue Symptomatology.  The Fatigue Symptom Inventory (FSI; Hann et al., 
1998) is a 13-item self-report measure of fatigue intensity, duration, and interference with 
quality of life in cancer patients (see Appendix G).  Regarding fatigue intensity, 
respondents indicate on an 11-point scale (0 = not at all fatigued to 10 = maximum 
fatigue) their most, least, and average fatigue level in the past week, as well as their 
current level of fatigue.  Then, seven items keyed to another 11-point scale (0 = no 
interference to 10 = extreme interference) are used to assess the level of interference 
caused by fatigue in the past week to the following areas:  general activity level, ability to 
bathe and dress, work activity, ability to concentrate, relations with others, enjoyment of 
life, and mood.  Finally, two duration items inquire about number of days in the past 
week the respondent has felt fatigued (0-7 days) and the percentage of each day that 
fatigue was experienced (0 = none of the day to 10 the entire day).  The FSI is a reliable 
and valid measure.  The internal consistency for the 7-item subscale measuring the level 
of interference caused by fatigue was above 0.90 for young and old cancer patients with a 
variety of cancer diagnoses, as well as healthy individuals (Hann, Denniston, & Baker, 
2000).  Regarding test-retest reliability, the FSI subscales produced low to moderate 
correlations between assessments.  Convergent, divergent, and construct validity have all 
been demonstrated for the FSI (Hann et al., 1998).  The 7-item subscale measuring the 
level of interference caused by fatigue was employed in this study with coefficient alphas 
for the breast cancer (.93) and non-cancer patient (.95) groups reflecting high internal 
consistency. 
Body Image.  The Body Exposure in Sexual Activities Questionnaire (BESAQ; 
Hangen and Cash, 1991) is a 28-item self-report questionnaire designed to assess body 
image during sexual activity, or personal ease with physical appearance during differing 
degrees of sexual activity (see Appendix H).  Specifically, it measures physical self-
consciousness and body exposure avoidance during sexual encounters. Participants are 
asked to rate on a 5-point Likert scale (0=never to 4 = always) how representative each 
item is of their own thoughts and beliefs during differing degrees of sexual activity.  
Items can be calculated into a total score, as well as separated into two subscales:  worry 
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 and self-consciousness (WSE) and comfort with body exposure (CBE).  The measure has 
high internal consistency for the scale as a whole (0.98), as well as for both the WSC 
(0.97) and CBE subscales (0.92) (Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999).  
The total score was utilized in the present study and coefficient alphas calculated for the 
breast cancer patients (.87) and the non-cancer patients (.90) reflect high internal 
consistency.  In a sample of 145 sexually active college-aged women, lower scores on the 
BESAQ (less anxiety or avoidant focus on their bodies) were found to be significantly 
(p< .01) correlated with higher sexual functioning scores.  The Body-Self Relations 
Questionnaire:  Appearance Evaluation Subscale (BSRQ—AES) is a subscale of the 
Multidimensional Body Self-Relations Questionnaire (MBSRQ; Cash, 1997).  The 
BSRQ—AES is a 7-item self-report questionnaire designed to assess both satisfaction 
and evaluation of the body (see Appendix I).  Participants are asked to rate on a 5-point 
Likert scale (1= definitely disagree to 5 = definitely agree) how representative each item 
is of their own thoughts and beliefs regarding satisfaction and evaluation of the body.  
The measure has high internal consistency for the scale as a whole (0.88) (Thompson et 
al., 1999).  In the present study, coefficient alphas of .90 for the breast cancer patients 
and .86 for the non-comparison group reflect high internal consistency.   The BRSQ—
AES has been used and has strong set of normative data (Brown, Cash, & Milulka, 1990; 
Cash, Ancis, & Strachan, 1997).   
 Marital Satisfaction. The Dyadic Adjustment Scale (DAS; Spanier, 1976) is a 32-
item multi-dimensional self-report measure designed to measure the quality of adjustment 
in both committed and marital relationships (see Appendix J).  Participants rate each item 
on a 7-poing Likert scale ranging from “extremely unhappy” to “perfect.”  The scale is 
split up into the following four subscales:  satisfaction, consensus, cohesion, and 
affectional expression.  The DAS is a reliable and valid measure.  The internal 
consistency reliability is high, with a range of 0.73 to 0.96 for all four subscales as well 
as the total summary score. This study employed the marital satisfaction and affectional 
expression subscales.  These scales demonstrated adequate to high internal consistency 
for the following breast cancer patients (.69 and .81, respectively) and the non-cancer 
comparison group (.81 and .77, respectively).   Content, criterion-related, and construct 
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 validity have all been established for the DAS (Busby, Christensen, Crane, & Larson, 
1995).     
Menopausal Symptoms.  The Breast Cancer Prevention Trial (BCPT) Symptom 
Checklist (Ganz, Day, Ware et al., 1998) is a 43-item self-report measure of physical and 
psychological symptoms associated with menopause as well as tamoxifen use (see 
Appendix K).    All symptoms are rated on how bothersome they have been in the past 4 
weeks using a 5-point Likert scale (0=not at all to 4=extremely).  Seven items make up 
three subscales that are specific to menopausal symptoms:  hot flash subscale, vaginal 
subscale, and urinary symptom subscale.  The internal consistency reliability is reported 
to be high, with alpha coefficients for each subscale above 0.73.  These three subscales 
can be added together to create the Symptoms Scale Score, which has been shown to 
have an internal consistency reliability of 0.50. The present study utilizes the vaginal 
subscale only.  The internal consistency reliability is low, demonstrated by coefficient 
alphas of .57 for breast cancer patients and .59 for the non-cancer comparison 
participants. 
Sexual Functioning.  The Sexual Function Questionnaire (SFQ; Syrjala et al., 
2000) is a 30-item multi-dimensional, self-report questionnaire designed to measure 
sexual functioning in both medically ill and healthy populations (see Appendix L).  The 
measure is composed of an Overall SFQ Score, two summary scales, Sexual Functioning 
and Treatment Impact, as well as the following nine subscales:  interest, desire, arousal, 
orgasm, satisfaction, activity, relationship, masturbation, and sexual problems.   
Respondents answer items based on 6-, 7-, or 11-point Likert scales keyed for the past 
month.  Approximately 10 minutes are needed to complete this questionnaire.  The SFQ 
is a reliable and valid measure.  The reported internal consistency for the overall SFQ 
score for women is high (α = .94), as are the internal reliabilities for all subscales 
(ranging from α=0.81 for sexual problems to α = 0.93 for orgasm). For both groups of 
women in this study,  the internal reliability for the overall SFQ score was high (α = .93)  
The internal reliabilities among the subscales are high for breast cancer patients (ranging 
from α=0.71 for desire to α = 0.97 for orgasm) and range from adequate to high for non-
cancer participants (ranging from α=0.65 for interest to α = 0.98 for masturbation). 
Content, criterion, and discriminant validity have all been demonstrated for the SFQ 
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 (Syrjala et al., 2000).  Due to researcher error, the problem subscale score was not 
obtained.  Therefore, the overall sexual functioning score and following eight subscales 
were used:  interest, relationship, desire, masturbation, activity, orgasm, satisfaction, and 
arousal. 
Statistical Power 
Statistical power was calculated based on the sample size obtained.  For between 
group differences, with 71 breast cancer patients and 40 non-cancer participants, there 
was power of .80 (p<.05, two tailed) to detect an effect size of between .5 and .6 standard 
deviation units (d = .55).  This corresponds to a medium effect size (Cohen, 1998).   
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Chapter Three 
 
Results 
 
Preliminary Analyses 
T-tests or chi-square analyses were conducted, as appropriate, to compare the 
breast cancer and non-cancer comparison groups on the demographic variables of age, 
household income, marital status, education, employment, and ethnicity.  Results 
revealed a marginally significant difference for employment status (p < .1) (see Table 1).  
Since employment status was not significantly correlated with the overall sexual 
functioning score on the SFQ (r = -0.12, p = .22), it was not included as a control variable 
in subsequent analyses.  Additional analyses indicated a significant difference between 
groups in menopausal status (p = .008), with breast cancer patients more likely to be 
postmenopausal.  Since menopausal status is likely to be affected by treatment for breast 
cancer, it was not included as a control variable in subsequent analyses.    
 Group Differences on Sexual Functioning Variables 
 It was hypothesized that a past diagnosis of breast cancer would be associated 
with more frequent and more severe sexual problems as measured by the SFQ overall 
score and the nine subscales:  interest, desire, arousal, orgasm, satisfaction, masturbation, 
activity, satisfaction with sexual relationship, and sexual problems.  As noted previously, 
due to researcher error, the sexual problems subscale was not collected.  Therefore, t-tests 
were performed on the overall score and on each of the remaining subscale scores to 
determine if significant differences existed between the breast cancer patients and the 
non-cancer comparison participants.  Contrary to predictions, there were no significant (p 
< .05) differences between the two groups on these variables (see Table 3). 
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 Relationship of Psychological and Physical Variables to Sexual Functioning 
   It was hypothesized that poorer overall sexual functioning would be associated 
with higher levels of fatigue, greater depressive symptomatology, greater marital 
dissatisfaction, poorer body image, and greater vaginal dryness.  As predicted, each of the 
psychological and physical variables was significantly (p  < .05) correlated with overall 
sexual functioning for the sample as a whole (see Table 4).  Specifically, scores on the 
CES-D, FSI, BESAQ, and vaginal subscale of the BCPT were all negatively correlated 
with overall sexual functioning.  The direction of these relationships indicates that, as 
expected, worse overall sexual functioning was associated with more severe depressive 
symptomatology (CES-D), more disruption from fatigue (FSI), poorer body image 
(BESAQ), and more problems with vaginal dryness, genital itching/irritation, and pain 
with intercourse (vaginal subscale of BCPT).   In addition, scores on the two DAS 
subscales of marital satisfaction and affectional expression, as well as on the appearance 
evaluation subscale of the BSRQ are all significantly (p < .05) positively correlated with 
overall sexual functioning.  The direction of these relationships indicates that, as 
expected, women who were more satisfied in their marital relationships (DAS marital 
satisfaction subscale), who are better able to express themselves emotionally (DAS 
affectional expression subscale), and who are satisfied with their physical appearance 
(BSRQ-AE) reported better overall sexual functioning. 
Group Differences on Psychological and Physical Variables  
Finally, it was hypothesized that a past diagnosis of breast cancer would be 
associated with higher levels of fatigue (as measured by the FSI), greater symptoms of 
depression (as measured by the CES-D), greater marital dissatisfaction (as measured by 
the two DAS subscales), less emotional expression (as measured by the DAS), poorer 
body image (as measured by the BESAQ and BSRQ-AE), and greater vaginal dryness (as 
measured by the vaginal problems subscale of the BCPT).  T-tests were performed on 
each of these psychological and physical variables to determine if significant differences 
existed between the breast cancer patients and the non-cancer comparison participants.  
Contrary to predictions, the groups only differed significantly on the vaginal problems 
subscale of the BCPT (t = 2.82; p = .006), with the breast cancer patients reporting more 
vaginal problems (see Table 5) than the non-cancer comparison participants. 
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 Additional Analyses 
Because conditions for a mediational model were not met, no further analyses in 
this vein were conducted.  However, additional analyses were pursued.  Because of prior 
research attesting to the intensity of chemotherapy and its effect on menopausal status 
(Ganz et al., 1998), the women who had received chemotherapy alone (n=7) or in 
conjunction with radiation (n=26) were combined and evaluated against the non-cancer 
comparison participants. T-tests were performed on the overall SFQ score and the eight 
subscales to determine if significant differences existed between the breast cancer 
patients who had received chemotherapy and the non-cancer comparison participants.  
Results mirror the results found for the sample as a whole.  Specifically, there were no 
significant differences between breast cancer patients treated with chemotherapy and a 
non-cancer comparison group on the overall score of sexual functioning on the SFQ or 
any of the eight subscales (see Table 6).   
 Finally, exploratory analyses were conducted to examine whether age might 
moderate the relationship between group membership (cancer vs. non-cancer) and sexual 
functioning.  Previous literature suggests (Schover et al., 1995) that some of the effects of 
cancer and its treatment might be more evident among younger women.   Toward this 
end, separate hierarchical multiple regression analyses were performed on the overall 
SFQ score and each of the eight subscales.  In each analysis, age and group membership 
were entered on the first step followed by the interaction of age and group membership 
on the second step.  Of particular interest was whether the interaction term accounted for 
additional significant variability in sexual functioning.  The interaction between age and 
breast cancer status did not account for a significant amount of variance  (p < .05) in the 
overall SFQ score or on any of the eight subscales scores (see Table 7).    
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Chapter Four 
 
Discussion 
 
 A goal of the present study was to determine whether sexual functioning was 
poorer in breast cancer survivors than women with no history of cancer.  In addition, the 
psychological and physical variables of depression, fatigue, marital satisfaction, body 
image, and vaginal problems were investigated as potential mediators of the hypothesized 
relationship between a history of breast cancer and sexual functioning.  This discussion 
will review the findings, consider the limitations of the current study, and discuss clinical 
implications and future research directions. 
 Contrary to predictions, women who completed treatment for breast cancer within 
the past five years did not report higher levels of sexual dysfunction when compared to 
women with no history of breast cancer.  These groups of women did not differ 
significantly on an overall measure of sexual function or on any of the eight individual 
subscales examining the sexual phases.  The variables of depression, fatigue, marital 
satisfaction, body image, and vaginal problems did correlate with sexual functioning in 
the predicted directions for this sample as a whole.  Specifically, as scores on the scales 
of depression, fatigue, body dissatisfaction, and vaginal problems increased, scores on a 
measure of sexual functioning decreased.  Likewise, as scores on measures of marital 
satisfaction and body satisfaction increased, scores on a measure of sexual functioning 
increased.  However, when the breast cancer patients and the non-cancer comparison 
participants were compared on these psychological and physical variables, they differed 
significantly only on reported number of vaginal concerns.  The lack of significant 
differences on these variables based on breast cancer status was contrary to initial 
hypotheses. 
 Based on previous research suggesting that treatment with chemotherapy may 
have a more damaging effect on women’s sexual functioning (Schover et al., 1995), we 
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 preformed additional analyses comparing only women treated with chemotherapy to the 
non-cancer comparison group.  This new grouping based on treatment received yielded 
similar non-significant results.  Finally, analyses were performed to look at the potential 
interactive effects of age and breast cancer status on sexual functioning.  This interaction 
was not found to contribute significantly to differences in sexual functioning. 
At first glance, these results do not appear to fit neatly into the current body of 
literature that posits a prevalence of sexual dysfunction in breast cancer survivors of 
anywhere from 15-37% (Schover et al., 1997) to 96% (Barni & Mondin, 1997).  
However, the current literature has known problems with sample selection and make-up 
(Ganz et al., 1998; Yurek et al., 2000; Gilbar et al., 1997), as well as measurement 
variability (Kiebert, et al., 1991).  Specifically, measurements of sexual functioning used 
often vary in their format, reliability, and validity oftentimes with researchers developing 
their own measures of sexual functioning.     
The current study did find evidence that vaginal problems were more common in 
cancer survivors.  This result may reflect the effects of tamoxifen that many of the 
women were receiving, as well as the high percentage (96%) of postmenopausal women.  
Most breast cancer patients are postmenopausal due to age at diagnosis or treatment 
effects (Ganz et al., 2000). These vaginal problems included vaginal dryness, genital 
itching/irritation, and pain with intercourse.  While difficulties with menopausal 
symptoms are not exclusive to breast cancer patients they may be intensified to due to 
tamoxifen use and effects of chemotherapy.   Previous research has shown that 
menopausal symptoms and sexual functioning can be improved with proper symptom 
assessment, education, counseling, and pharmacologic and behavioral interventions 
(Ganz et al., 2000). 
Limitations 
 This study has several limitations that need to be addressed.  The samples for the 
current study consisted primarily of Caucasian, well-educated, higher income women.  
This feature may limit the generalizability of the findings to populations more diverse 
with regard to race/ethnicity, education, and socioeconomic status.  The relatively low 
response rate of 28% for breast cancer patients and 59% for non-cancer comparisons is 
another major limitation.  A systematic bias may have existed connected with whether or 
21  
 not a woman agreed to participate.  For example, it is possible that women with more 
severe problems in sexual functioning may have declined to participate.  The use of 
cross-sectional design that includes a sample of patients with considerably varied time 
since diagnosis is another limitation.  This feature limits the ability to make conclusions 
about the time course of problems in sexual functioning.  Statistical power is yet another 
limitation.  Although the sample size had power adequate to detect a medium effect, 
sexual functioning may have been a smaller than medium effect.  Finally, all data was 
collected via self-report without any corroborating objective measures of sexual 
functioning.  Ideally, corresponding data would also have been collecting from spouses 
and partners. 
Future Directions 
 Whenever possible, future research should strive to include a non-patient 
comparison group in order to identify any needs that set cancer patients apart from those 
with no cancer history.  Longitudinal research employing pre-treatment baseline 
assessments, as well as larger and more demographically diverse samples would allow 
for a better understanding of sexual functioning over time, as well as any potential 
cultural and demographic differences.  Comparison studies between cancer patients by 
age of diagnosis, disease stage, and treatment type also may shed light on how these 
medical variables affect sexual functioning outcomes.  In addition, new procedures 
should be employed to increase participation.  With the use of websites and e-mails 
versus telephone and mail, faster and more efficient recruitment may be possible.  
The number of breast cancer patients who did report vaginal problems warrants 
more intervention studies.  The Ganz et al. (2000) intervention study was able to reduce 
menopausal symptoms and improve sexual functioning.  Future research should seek to 
continue to study interventions that could better educate, inform, and normalize this 
experience for breast cancer survivors.    
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 Table 1 
Demographic Characteristics of Breast Cancer Patients and Non-Cancer Comparison 
Participants 
 
        Non-Cancer 
                                        Breast Cancer Patients          Participants                                
 
       N           (%)  N      (%)  χ2      p  
 
Race     1.74 .18 
       
    White 68 (96%) 40 (100%)   
    Non-White 3 (4%) 0 (0%)   
       
Marital Status       
            .30 .58 
    Married 66 (93%) 36 (90%)   
    Not Married 5 ( 7%) 4 (10%)   
       
Education     1.78 .18 
       
    < 12 years 14 (20%) 4 (10%)   
    > 12 years 57 (80%) 36 (90%)   
       
Employment      3.63 .06* 
       
   Employed 40 (56%) 15 (38%)   
   Not employed 31 (44%) 25 (62%)   
       
Household Income     2.2  .33 
       
   < $40,000 10 (14%) 4 (10%)   
   > $40,000 51 (72%) 26 (65%)   
  Did not answer 10 (14%) 10 (25%)   
       
Menopausal Status     7.13 .008**
       
   Pre- or    
perimenopausal 
3 (4%) 8 (20%)   
   Postmenopausal 68 (96%) 32 (80%)   
 
 
*p < .1 
**p < .05
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Table 2 
Medical Characteristics of Breast Cancer Patients (N = 71) 
 
 
                                 N                                (%)   
  
 
Stage 
  
   
             0  10 14% 
             I 29 41% 
             II 32 
 
45% 
   
Surgery Type          
      
             Lumpectomy     59 84% 
             Mastectomy 10 14% 
             Bilateral Lumpectomy 1 1% 
             Bilateral Mastectomy 1 1% 
   
Reconstructive Surgery       
   
             None 63 88% 
             Immediate 4 6% 
             Delayed 4 6% 
   
Treatment Received   
   
             Chemo only 7 10% 
             Chemo and XRT 26 37% 
             XRT only 38 53% 
   
Time Since Diagnosis   
   
             1 - 2 years 2 3% 
             2 – 3 years 10 14% 
             3 – 4 years 30 42% 
             4 – 5 years 29 41% 
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 Table 3 
 
Comparison Between Breast Cancer Patients and Non-Cancer Participants on Sexual 
Functioning Questionnaire   
 
                     Non-Cancer  
       Breast Cancer Patients           Participants    
                SFQ                                   SFQ    
   
                          M (SD)                               M (SD)                   t             p 
 
 
 
Overall Score 
 
2.41 (0.88) 
 
 
2.50 (0.89) 
 
 
-0.47 
 
.64 
 
 
Interest Subscale 
 
1.50 (1.05) 
 
 
1.49 (0.87) 
 
 
0.05 
 
.96 
 
 
Desire Subscale 
 
2.80 (1.21) 
 
 
2.84 (1.43) 
 
 
-0.17 
 
.86 
 
 
Arousal Subscale 
 
1.77 (1.19) 
 
 
1.69 (1.14) 
 
 
0.33 
 
.74 
 
 
Orgasm Subscale 
 
3.39 (1.68) 
 
 
3.80 (1.68) 
 
 
-1.24 
 
.22 
 
 
Satisfaction Subscale 
 
3.04 (1.68) 
 
 
3.44 (1.83) 
 
 
-1.18 
 
.24 
 
 
Activity Subscale 
 
2.63 (1.46) 
 
 
2.60 (1.34) 
 
 
0.10 
 
.92 
 
 
Relationship Subscale 
 
3.07 (1.08) 
 
 
3.24 (1.11) 
 
 
-0.78 
 
.44 
 
 
Masturbation Subscale 
 
0.62 (0.99) 
 
 
0.57 (1.02) 
 
 
0.26 
 
.80 
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Table 4 
 
Correlational Analyses of Psychological and Physical Variables with Sexual Functioning 
Questionnaire (SFQ) Overall Score 
 
 
 
 SFQ  
Overall  
Score 
 
Depressive Symptomatology (CES-D) 
 
-0.31** 
 
 
Fatigue (FSI) 
 
-0.23* 
 
 
Marital Satisfaction (DAS Marital Satisfaction Subscale) 
 
 
 0.56*** 
 
Emotional Expression (DAS Affectional Expression Subscale) 
 
 
 0.44*** 
 
Body Image (BESAQ) 
 
-0.41*** 
 
 
Body Image (BSRQ) 
 
 
0.26* 
 
Vaginal Problems (BCPT Vaginal Subscale) 
 
-0.24* 
 
     
* p<.05 
**p<.001 
***p<.0001 
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Table5 
 
Comparison Between Breast Cancer Patients and Non-Cancer Participants on 
Psychological and Physical Variable Scores  
 
                                                    Non-Cancer 
  Breast Cancer Patients           Participants 
             
                                                M (SD)       M (SD)  t      p  
 
 
 
CES-D (depression) 
 
9.23 (8.78) 
 
 
6.73 (7.94) 
 
 
1.90 
 
.06 
 
 
FSI (fatigue) 
 
1.41 (1.67) 
 
 
1.37 (1.88) 
 
 
0.12 
 
.91 
 
 
DAS—Marital 
Satisfaction Subscale 
 
8.60 (2.20) 
 
 
8.62 (2.84) 
 
 
-0.09 
 
.93 
 
 
DAS—Affectional 
Expression Subscale 
 
38.42 (5.15)  
 
 
38.19 (4.84) 
 
 
0.23 
 
.82 
 
BESQ (body image) 
 
36.11 (21.53) 
 
 
34.92 (21.15) 
 
 
0.26 
 
.80 
 
 
BSRQ (body image) 
 
2.23 (0.95) 
 
 
2.41 (0.73) 
 
 
-1.03 
 
.31 
 
 
BCPT—Vaginal 
Subscale 
 
3.69 (2.65) 
 
 
2.21 (2.53) 
 
 
2.82 
 
.0057*
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Table 6 
 
Comparison Between Breast Cancer Patients Treated with Chemotherapy and Non-
Cancer Comparison Participants on Sexual Functioning Questionnaire 
 
                                                     Non-Cancer  
       Breast Cancer Patients   Participants     
                      SFQ                    SFQ 
              
                                                       M (SD)                       M (SD)                     t             p 
 
 
 
Overall Score 
 
2.17 (0.90) 
 
 
2.50 (0.89) 
 
 
-1.50 
 
.14 
 
 
Interest Subscale 
 
1.47 (1.05) 
 
 
1.49 (0.87) 
 
 
- 0.08 
 
.94 
 
 
Desire Subscale 
 
2.57 (1.26) 
 
 
2.84 (1.43) 
 
 
-0.87 
 
.39 
 
 
Arousal Subscale 
 
1.58 (1.05) 
 
 
1.69 (1.14) 
 
 
-0.44 
 
.66 
 
 
Orgasm Subscale 
 
3.10 (1.68) 
 
 
3.80 (1.68) 
 
 
-1.75 
 
.08 
 
 
Satisfaction Subscale 
 
2.69 (1.64) 
 
 
3.44 (1.83) 
 
 
-1.84 
 
.07 
 
 
Activity Subscale 
 
2.40 (1.51) 
 
 
2.60 (1.34) 
 
 
- 0.62 
 
.54 
 
 
Relationship Subscale 
 
2.90 (1.12) 
 
 
3.24 (1.11) 
 
 
-1.27 
 
.21 
 
 
Masturbation Subscale 
 
0.65 (0.95) 
 
 
0.57 (1.02) 
 
 
0.34 
 
.74 
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 Table 7 
 
Significance of Interaction of Age and Group Membership for Each Scale of the SFQ 
         
 
 
 β F p 
 
Overall Score 
 
 
-.72 
 
1.11 
 
.30 
 
Interest Subscale 
 
 
-.57 
 
.77 
 
.38 
 
Desire Subscale 
 
 
-.87 
 
1.86 
 
.18 
 
Arousal Subscale  
 
 
-.37 
 
.33 
 
.57 
 
Orgasm Subscale 
 
 
.33 
 
.27 
 
.60 
 
Satisfaction Subscale 
 
 
-.07 
 
.01 
 
.92 
 
Activity Subscale 
 
 
-.22 
 
.12 
 
.73 
 
Relationship Subscale 
 
 
-.53 
 
.66 
 
.42 
 
Masturbation Subscale 
 
 
-.37 
 
.33 
 
.57 
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 Figure 1.  Flow chart of recruitment for breast cancer patients 
 
 
 
 
 
563  
introductory 
letters sent 
 
230 unable to be contacted
 
• 211 Not answered 
• 19   Disconnected 
 
333 contacted
 
179 refused to participate 
 
• 57 Called decline line 
• 57 Verbally agreed but failed to 
return packet 
• 17 Not interested 
• 17 Declined after receiving packet 
o 9 Uncomfortable with subject
o 3 Not interested 
o 2 Uncomfortable with consent
o 2 Sick spouse 
o 1 Time 
• 10 Uncomfortable with subject 
• 9   No time 
• 5   Ill (non-cancer related) 
• 3   Hate paperwork 
• 3   Caretaking 
• 1   Avoiding talking about cancer 
 
83 ineligible 
 
• 49 No partner 
• 13 Dx date out of range 
•  5  Other cancer dx 
•  5  Recurrence 
•  3  Stage III disease 
•  3  Language Barrier 
•  2  No annual oncologist visit 
•  2  Deceased 
•  1 Other medical problems 
 
 
250  contacted 
and eligible 
71 
questionnaires 
analyzed 
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 Figure 2.  Flow chart of recruitment for non-cancer participants 
 
 
  
 
 
 
 
 
123 women 
nominated 
 
22 unable to be contacted 
 
• 19 Not answered 
• 3  Wrong contact info 
 
101 contacted
 
34 refused to participate 
 
• 16 Verbally agreed but failed to 
return packet 
•  9  Not interested 
•  5  Uncomfortable with subject matter
•  4  No time 
 
 
18 ineligible 
 
• 10  No partner 
•  7  Cancer history 
•  1  Deceased 
49 eligible 
questionnaires 
returned 
 
83 contacted 
and eligible 
9 
questionnaires 
deleted for 
procedural 
purposes 
40 
questionnaires 
analyzed 
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 Appendix A:   Introductory Letter for Breast Cancer Patients 
 
 
 
To Our Patients, 
 
As part of our continuing efforts to improve patient care, we are asking selected patients 
treated by the Breast Program at Moffitt Cancer Center and their friends to participate in 
a research study.  This study is being conducted in collaboration with Heidi Grenke, B.A. 
and Paul Jacobsen, Ph.D. from Moffitt’s Psychosocial and Palliative Care Program.  They 
are interested in assessing quality of life, including sexual functioning, in women with  
and without a past history of breast cancer.  In order to do so, they need to collect 
information from women with a history of breast cancer, as well as women of the same 
age without a history of breast cancer.  Although sexual functioning is a sensitive topic, it 
is an important concern for many breast cancer survivors.  Only through research in this 
area, will we be able to better assess and treat the concerns of breast cancer survivors. 
 
Participation would entail completing a brief packet of questionnaires that takes 
approximately 25 minutes to finish. The information you can provide will be important in 
helping us better assess the types of changes women with breast cancer experience, so 
that we might better plan for their care.  
 
If you do not wish to learn more about this study, please call (813) 903-4606 or  
1-800-456-3434 x4606 and you will not be contacted further.  Otherwise, within the next 
week, you will receive a phone call from Heidi Grenke in order to provide additional 
information about how to participate in this study.  
 
I greatly appreciate your taking the time to consider this request. 
 
Sincerely,  
 
 
Karen Fields, M.D. 
Program Leader, Breast Program 
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 Appendix B:  Telephone Script for Breast Cancer Participants 
 
 
Hello, my name is Heidi Grenke and I am a graduate student at the University of South 
Florida doing research at the Moffitt Cancer Center.  Currently, I am doing a study along 
with Dr.  _________ and the other doctors in the Breast Program.  Last week, you should 
have received a letter from us describing a study we are currently doing on the quality of 
life of women who have been diagnosed with cancer in the past 5 years.   
  
Did you receive that letter?   
 
Is now a good time to tell you a little bit more about the study? 
 
We are most interested in finding out how you are feeling both physically and 
emotionally now that treatment has ended and time has passed.  If you agree to 
participate, we will be asking for some of your time and input.  We will be mailing you 
out a questionnaire packet that will include questions about your mood, level of fatigue, 
body image, and sexual functioning.  This packet will take approximately 45 minutes to 
complete.  While some of the questions about sexual functioning will seem quite 
personal, I want to guarantee you that all information will be kept strictly confidential.  
The information you provide will help us to learn more about how to assist patients in 
coping with possible side effect of cancer treatment over time. 
 
We will also be asking you to nominate female friends within 5 years of your age that 
would also be willing to complete a questionnaire for this study.  We are asking women 
without a breast cancer diagnosis to also complete the questionnaire so that we can 
determine whether or not the quality of life of women treated for breast cancer differs 
from that of the quality of life of women of similar age and circumstances NOT 
diagnosed with breast cancer. 
Does this sound like something you might be interested in? 
I have a few questions to ask you, to ensure that this study is a good fit for you. 
1. When were your first diagnosed with breast cancer?  _____________ 
2. Have you seen your oncologist in the past year? 
3. What did he/she say? 
4. Have you ever been diagnosed with any other type of cancer (r/o if other than 
basal cell)? 
5. Do you have any other medical conditions that we should be aware of? 
6. Do you have a spouse or partner with whom you are currently sexually active? 
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 Appendix C:  Recruitment Invitation for Non-Cancer Participants 
 
 
 
Dear ___________________________, 
 
I am taking part in a research study that looks at the impact of breast cancer treatment on quality 
of life.  This study is being done through the H. Lee Moffitt Cancer Center and Research Institute, 
where I received my care, and focuses on sexual functioning in breast cancer survivors.  One 
important aspect of the study is to compare the reports of women who received breast cancer 
treatment with those women without cancer (‘healthy controls’).  This information will help the 
researchers at Moffitt identify the specific needs of women treated for breast cancer. 
I have nominated you to be invited to take part in this study as a ‘healthy control’.  One of the 
researchers at Moffitt, Heidi Grenke, will call you within the next week to further explain the 
study.  Taking part in this study would involve completing a questionnaire packet (which should 
take about 25 minutes to complete) by mail on one occasion. 
This type of research is needed so that doctors can improve their skills in helping women manage 
the effects of breast cancer treatment and experience better quality of life.  I encourage you to 
take part in the study and I hope you will agree to participate. 
 
Sincerely,  _______________________________ 
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 Appendix D:  General Background Information Form for Breast Cancer Patients 
 
We appreciate your participation in this project; we could not complete it without you. 
Your answers will remain completely confidential.  Thank you for your time. 
 
 
1. Today's date:    /    /   (month/day/year)  
  
2. Your birth date:    /  /    (month/day/year) 
  
3. Height      (ft)    (in) 
  
4.   Weight     (pounds) 
  
 
5. Which of the following best describes your ethnic background? 
  
     1  Spanish/Hispanic/Latino 
  2  Not Spanish/Hispanic/Latino 
 
6. What is your race? (check one box) 
  
   1  White/Caucasian    4  American Indian/Alaska Native  
   2  Black/African American   5   Other: ______________ 
   3  Asian/Pacific Islander  
 
7. What is the highest grade or level of education you have completed? (check one 
box) 
  
     1  8th grade or less           4  Vocational school or some college 
     2  Some high school (grade 9 to 12)    5  College or university graduate 
     3  High school graduate or GED          6  Professional or graduate school 
 
8. What category best describes your usual occupation?  If you are not currently 
employed, which category best describes your LAST job?  (check one box) 
   
   1  Professional (e.g., teacher/professor, nurse, lawyer, physician, engineer) 
   2  Manager/Administrator (e.g., sales managers) 
   3  Clerical (e.g., secretaries, clerks, or mail carriers) 
   4  Sales (e.g., sales persons, agents, and brokers) 
   5  Service (e.g., police, cooks, waitress, or hairdressers) 
   6  Skilled Crafts, Repairer (e.g., carpenters)  
   7  Equipment or Vehicle Operator (e.g., truck drivers) 
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 Appendix D:  General Background Information Form for Breast Cancer Patients 
(Continued) 
 
   8  Laborer (e.g., maintenance factory workers) 
    9   Farmer (e.g., owners, managers, operators, or tenants) 
    10 Member of the military 
    11 Homemaker (with no job outside the home) 
    12 Other (please describe)______________________________________ 
 
 
9. Which category best describes your spouse/partner’s usual occupation?  If your 
spouse/partner is notcurrently employed, which category best describes his/her 
LAST job?  (check one box) 
 
    1  Professional (e.g., teacher/professor, nurse, lawyer, physician,engineer) 
    2  Manager/Administrator (e.g., sales managers) 
    3  Clerical (e.g., secretaries, clerks, or mail carriers) 
    4  Sales (e.g., sales persons, agents, and brokers) 
    5  Service (e.g., police, cooks, waitress, or hairdressers) 
   6  Skilled Crafts, Repairer (e.g., carpenters)  
   7  Equipment or Vehicle Operator (e.g., truck drivers) 
   8  Laborer (e.g., maintenance factory workers) 
    9  Farmer (e.g., owners, managers, operators, or tenants) 
   10 Member of the military 
    11 Homemaker (with no job outside the home) 
  12 Other (please describe)_________________________________________ 
 
10. Which of the following best describes your current employment situation? (check 
one box) 
  
    1  Paid full-time employment    8  Student full-time 
    2  Paid part-time employment    9  Student part-time 
    3  Self-employed      10 Homemaker    
    4  On leave with pay     11 Volunteer 
    5  On leave without pay     12 Unemployed-looking for work 
    6  Not employed - disabled    13 Unemployed-not looking for work 
    7  Not employed – retired  
 
11. What is your approximate annual gross income? (check one box) 
        1  Less than $ 10,000        4  $40,000 - $74,999  
               2  $10,000 - $19,999        5  $75,000 or more 
               3  $20,000 - $ 39,999        6  Prefer not to answer 
 
43  
 Appendix D:  General Background Information Form for Breast Cancer Patients 
(Continued) 
 
12. What was your total household income (from all sources) before taxes in the last 
calendar year?  Your answer will remain completely confidential.  (check one 
box)  
  
               1  Less than $ 10,000        4  $40,000 - $74,999  
               2  $10,000 - $19,999        5  $75,000 or more 
               3  $20,000 - $ 39,999        6  Prefer not to answer 
 
13. When were you first diagnosed with breast cancer? 
     /   (month/year) 
 
14. Which of the following have you received? (check all that apply) 
  
    1  Lumpectomy to remove the cancer 
    2  Mastectomy to remove the cancer 
    3  Lumpectomy + mastectomy to remove the cancer 
    4  Bilateral Mastectomy to remove the cancer 
    5  Breast reconstruction 
   6  Radiation therapy 
  7  Chemotherapy before your breast cancer surgery 
  8  Chemotherapy after your breast cancer surgery 
   9  Hormonal therapy to shrink or reduce the cancer (ex: Tamoxifen) 
   10 Hormonal therapy to prevent another cancer (ex:  Tamoxifen) 
  11 Other (describe______________________________________) 
 
15.  When did you finish chemotherapy treatments? 
     1 I did not receive chemotherapy treatment. 
     2 I finished chemotherapy treatments on    /                        
(month/year) 
 
16. When did you finish radiation treatments? 
  
     1 I did not receive radiation treatment. 
      2 I finished radiation treatments on     /     
            (month/year) 
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 Appendix D:  General Background Information Form for Breast Cancer Patients 
(Continued) 
 
17. Which of the following best describes how you presently function? (check one 
box) 
     1  I am able to carry on normal activity or do work and I have no 
physical complaints or   problems. 
    2  I am able to carry on normal activity or do work even with minor 
physical complaints. 
    3  I am able to carry on normal activity or do work but it takes effort 
because of physical problems.  
    4  I am unable to carry on normal activity but I care for myself. 
    5  I am unable to carry on normal activity and I require occasional help 
from others, but I am able to care for most of my personal needs. 
    6  I require considerable help from others and I require frequent 
medical care. 
  7  I am disabled and I require special care and help. 
 
18. Do you take prescription medication regularly? 
       1  Yes     
      2  No     
 
19. Are you currently taking Tamoxifen? 
  
       1  Yes  
     2  No   
  
  
 If yes: 
Dose:                          Since:   
 
 ________________________________ ______________________________ 
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 Appendix D:  General Background Information Form for Breast Cancer Patients 
(Continued) 
 
20. What medications, other than Tamoxifen, do you currently take? 
  
 Drug:   Dose:   Since:  Reason: 
 
 ______________ ____________             ________ __________________ 
______________ ____________             ________ __________________ 
______________ ____________             ________ __________________ 
______________ ____________             ________ __________________ 
 
21. Please indicate your sexual orientation (check one box). 
  
     1  Heterosexual 
     2  Homosexual 
     3  Bisexual 
     4  Prefer not to answer   
 
 
22. What is your current marital status?  (check one box) 
  
     1  Single, never married       4  Divorced 
     2  Married        5  Widowed 
       3  Living in a marriage-like relationship     6  Separated  
 
 
23. Length of time you have been with your current partner (check one box): 
  
     1  Less than 6 months       4  Two to 5 years 
     2  Six months to 1 year       5  More than 5 years 
       3  One to 2 years     
 
 
24. Were you with this current partner before your breast cancer diagnosis? 
  
     1  Yes 
     2  No  
 
 
25. Does your partner have any difficulty with sexual desire, becoming sexually 
aroused, or achieving orgasm? 
  
     1  Yes  (Go to question 26) 
     2  No   (Go to question 27) 
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Appendix D:  General Background Information Form for Breast Cancer Patients 
(Continued) 
 
26. When did your partner start having difficulties with sexual desire, becoming 
sexually aroused, or achieving orgasm? 
  
    /   (month/year) 
 
 
27. Prior to your breast cancer diagnosis, did you have any difficulties with sexual 
desire, becoming sexually aroused, or achieving orgasm? 
  
     1  Yes (Go to question 28) 
     2  No   (Go to question 29) 
 
 
 
28. When did you start having difficulties with sexual desire, becoming sexually 
aroused, or achieving orgasm? 
  
    /   (month/year) 
 
 
29. Current living arrangement (check one box): 
   
     1  Live alone      5  Live with roommate who is not partner 
     2  Live with spouse/partner     6  Live with parents 
     3  Live with spouse/partner and children      7  Other (specify:__________) 
     4  Live with children (no spouse/partner) 
 
 
30. How long in current living arrangement (check one box): 
  
     1  Less than 1 month       4  Between 2 to 5 years 
     2  One to 6 months       5  More than 5 years 
     3  Seven months to 2 years  
 
31.  Number of children under 18 living at home:    
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 Appendix E:  General Background Information Form for Non-Cancer Participants 
 
We appreciate your participation in this project; we could not complete it without you. 
Your answers will remain completely confidential.  Thank you for your time. 
 
 
1. Today's date:    /    /   (month/day/year)  
2. Your birth date:    /  /    (month/day/year) 
 
3. Height      (ft)    (in) 
 
4.   Weight     (pounds) 
  
 
5. Which of the following best describes your ethnic background? 
  
     1  Spanish/Hispanic/Latino 
  2  Not Spanish/Hispanic/Latino 
 
6. What is your race? (check one box) 
 
   1  White/Caucasian    4  American Indian/Alaska Native  
   2  Black/African American   5  Other: _________________________ 
   3  Asian/Pacific Islander  
 
 
7. What is the highest grade or level of education you have completed? (check one 
box) 
   
    1  8th grade or less        4  Vocational school or some college 
     2  Some high school (grade 9 -12)      5  College or university grad 
     3  High school graduate or GED       6  Professional or graduate school  
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 Appendix E:  General Background Information Form for Non-Cancer Participants 
(Continued) 
 
8. What category best describes your usual occupation?  If you are not currently 
employed, which category best describes your LAST job?  (check one box) 
   
      1  Professional (e.g., teacher/professor, nurses, lawyer, physician, engineer) 
      2  Manager/Administrator (e.g., sales managers) 
      3  Clerical (e.g., secretaries, clerks, or mail carriers) 
      4  Sales (e.g., sales persons, agents, and brokers) 
      5  Service (e.g., police, cooks, waitress, or hairdressers) 
      6  Skilled Crafts, Repairer (e.g., carpenters)  
      7  Equipment or Vehicle Operator (e.g., truck drivers) 
      8  Laborer (e.g., maintenance factory workers) 
      9  Farmer (e.g., owners, managers, operators, or tenants) 
      10 Member of the military 
      11 Homemaker (with no job outside the home) 
      12 Other (please describe)________________________________________ 
 
9. Which category best describes your spouse/partner’s usual occupation?  If your 
spouse/partner is not currently employed, which category best describes his/her 
LAST job?  (check one box) 
 
      1  Professional (e.g., teacher/professor, nurse, lawyer, physician, engineer) 
      2  Manager/Administrator (e.g., sales managers) 
      3  Clerical (e.g., secretaries, clerks, or mail carriers) 
      4  Sales (e.g., sales persons, agents, and brokers) 
      5  Service (e.g., police, cooks, waitress, or hairdressers) 
      6  Skilled Crafts, Repairer (e.g., carpenters)  
      7  Equipment or Vehicle Operator (e.g., truck drivers) 
      8  Laborer (e.g., maintenance factory workers) 
      9  Farmer (e.g., owners, managers, operators, or tenants) 
      10 Member of the military 
      11 Homemaker (with no job outside the home) 
      12 Other (please describe)_______________________________________ 
 
10. Which of the following best describes your current employment situation? (check 
one box) 
  
      1  Paid full-time employment       8  Student full-time 
      2  Paid part-time employment       9  Student part-time 
      3  Self-employed         10 Homemaker    
      4  On leave with pay        11 Volunteer 
      5  On leave without pay        12 Unemployed-looking for work 
      6  Not employed - disabled       13 Unemployed-not looking for work 
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 Appendix E:  General Background Information Form for Non-Cancer Participants 
(Continued) 
 
11. What is your approximate annual gross income? (check one box) 
        1  Less than $ 10,000        4  $40,000 - $74,999  
               2  $10,000 - $19,999        5  $75,000 or more 
               3  $20,000 - $ 39,999        6  Prefer not to answer 
 
12. What was your total household income (from all sources) before taxes in the last 
calendar year? (check one box)  
  
               1  Less than $ 10,000        4  $40,000 - $74,999  
               2  $10,000 - $19,999        5  $75,000 or more 
               3  $20,000 - $ 39,999        6  Prefer not to answer 
 
13. Which of the following best describes how you presently function? (check one 
box) 
     1  I am able to carry on normal activity or do work and I have no 
physical complaints or problems. 
    2  I am able to carry on normal activity or do work even with minor 
physical complaints. 
    3  I am able to carry on normal activity or do work but it takes effort 
because of physical problems.  
    4  I am unable to carry on normal activity but I care for myself. 
    5  I am unable to carry on normal activity and I require occasional help 
from others, but I am able to care for most of my personal needs. 
    6  I require considerable help from others and I require frequent 
medical care. 
    7  I am disabled and I require special care and help. 
 
14. Do you take prescription medication regularly? 
       1  Yes  (Go to question 15)   
      2  No    (Go to question 16) 
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 Appendix E:  General Background Information Form for Non-Cancer Participants 
(Continued) 
 
15. What medications do you currently take? 
  
 Drug:   Dose:   Since:  Reason: 
 
 ______________ ____________             ________ __________________ 
______________ ____________             ________ __________________ 
______________ ____________             ________ __________________ 
 
16. Please indicate your sexual orientation. (check one box) 
  
     1  Heterosexual 
     2  Homosexual 
     3  Bisexual 
     4  Prefer not to answer   
 
 
17. What is your current marital status?  (check one box) 
  
     1  Single, never married       4  Divorced 
     2  Married        5  Widowed 
       3  Living in a marriage-like relationship     6  Separated  
 
 
 
18. Length of time you have been with your current partner (check one box): 
  
     1  Less than 6 months       4  Two to 5 years 
     2  Six months to 1 year       5  More than 5 years 
       3  One to 2 years     
 
 
19. Does your partner have difficulties with sexual desire, becoming sexually 
aroused, or achieving orgasm? 
  
     1  Yes  (Go to question 20) 
     2  No   (Go to question 21) 
 
 
20. When did your partner start having difficulties with sexual desire, becoming 
sexually aroused, or achieving orgasm? 
  
    /   (month/year) 
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 Appendix E:  General Background Information Form for Non-Cancer Participants 
(Continued) 
 
21. Do you have any difficulties with sexual desire, becoming sexually aroused, or 
achieving orgasm? 
  
     1  Yes (Go to question 22) 
     2  No   (Go to question 23) 
 
 
 
22. When did you start having difficulties with sexual desire, becoming sexually 
aroused, or achieving orgasm? 
  
    /   (month/year) 
 
 
23. Current living arrangement (check one box): 
   
     1  Live alone      5  Live with roommate who is not partner 
     2  Live with spouse/partner     6  Live with parents 
     3  Live with spouse/partner and children      7  Other (specify:__________) 
     4  Live with children (no spouse/partner) 
 
 
24. How long in current living arrangement (check one box): 
  
     1  Less than 1 month      4  Between 2 to 5 years 
     2  One to 6 months       5  More than 5 years 
      3  Seven months to 2 years 
 
 
 
25.  Number of children under 18 living at home:    
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 Appendix F:  Center for Epidemiologic Studies, Depression Scale 
 
For each statement below, make an “X” in the box which best describes how often you 
felt or behaved this way-- DURING THE PAST WEEK, INCLUDING TODAY. 
 
      None of A Little of A Moderate Most  
          the Time  the Time Amount of of the  
            Time  Time 
DURING THE PAST WEEK:             
1. I was bothered by things that 
usually don't bother me                     .........            
2. I did not feel like eating; my 
appetite was poor.  .........            
3. I felt that I could not shake off the 
blues even with help from my  
family or friends  .........            
4. I felt that I was just as good as 
other people  .........            
5. I had trouble keeping my mind on  
what I was doing  .........            
6. I felt depressed  .........            
7. I felt that everything I did was  
an effort  .........            
8. I felt hopeful about the future  .........            
9. I thought my life had been a failure  .........            
10. I felt fearful  .........            
11. My sleep was restless  .........            
12. I was happy  .........           
13. I talked less than usual  .........            
14. I felt lonely  .........                        
15. People were unfriendly  .........            
16. I enjoyed life  .........            
17. I had crying spells  .........            
18. I felt sad  .........            
19. I felt that people disliked me  .........            
20. I could not “get going”  .........          
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 Appendix G: Fatigue Symptom Inventory 
 
For each of the following, circle the one number that best indicates how that item applies 
to you.  
1. Rate your level of fatigue on the day you felt most fatigued during the past week. 
0 1 2 3 4 5 6  7 8 9 10 
Not at all         As fatigued   
fatigued         as I could be 
 
2. Rate your level of fatigue on the day you felt least fatigued during the past week. 
0 1 2 3 4 5 6  7 8 9 10 
Not at all         As fatigued   
fatigued         as I could be 
 
3. Rate your level of fatigue on the average in the last week. 
0 1 2 3 4 5 6  7 8 9 10 
Not at all         As fatigued   
fatigued         as I could be 
 
4. Rate your level of fatigue right now. 
0 1 2 3 4 5 6  7 8 9 10 
Not at all         As fatigued   
fatigued         as I could be 
 
5. Rate how much, in the past week, fatigue interfered with your general level of 
activity: 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme    
interference        
 interference 
 
6. Rate how much, in the past week, fatigue interfered with your ability to bathe and 
dress  yourself: 
0 1 2 3 4 5 6  7 8 9 10 
No           Extreme     
interference           interference 
 
7. Rate how much, in the past week, fatigue interfered with your normal work activity      
 (includes both work outside the home and housework): 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme        
   interference            interference 
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 Appendix G: Fatigue Symptom Inventory (Continued) 
 
8.  Rate how much, in the past week, fatigue interfered with your ability to concentrate 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme  
interference                      interference 
 
9. Rate how much, in the past week, fatigue interfered with your relations with other 
people: 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme      
interference            interference 
 
10. Rate how much, in the past week, fatigue interfered with your enjoyment of life: 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme    
interference           interference 
 
11. Rate how much, in the past week, fatigue interfered with your mood: 
0 1 2 3 4 5 6  7 8 9 10 
No          Extreme    
 
12. Indicate how many days, in the past week, you felt fatigued for any part of the day: 
0 1 2 3 4 5 6 7 
   Days               Days 
 
13. Rate how much of the day, on average, you felt fatigued in the past week: 
0 1 2 3 4 5 6 7 8 9 10 
None of           The entire  
the day              day  
 
14. Indicate which of the following best describes the daily pattern of your fatigue in the        
 past week: 
0    1  2  3           4 
Not at all        Worse in     Worse in the     Worse in  No consistent daily  
       fatigued          the morning     afternoon     the evening       pattern of fatigue                     
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Appendix H:  Body Exposure in Sexual Activities Questionnaire 
 
If you have not engaged in sexual activity in the last six months, please mark  
an “X” in this box   and proceed on to the next questionnaire.  
  
We are interested in the thoughts and behaviors that an individual may experience  
or enact during sexual encounters.  Read each statement carefully and identify how 
characteristic it is of you and your experience using the following code: 
       
               Never    Rarely   Sometimes  Often Always 
1. During sexual activity I am constantly  
 thinking that my partner will notice  
  something about my body that is a  
 turnoff……….                                         
      
2.   During sexual activity I worry that my                          
   partner will find aspects of my physique 
   unappealing……………….                  
 
3.   During sexual activity I am aware of   
   how my body looks…………………                 
 
4.   During sexual activity something about  
  the way my body looks makes me feel              
  inhibited……………………….    
 
5.  I am uncomfortable when undressed by  
  my partner……           
 
6.   I prefer to keep my body hidden under   
  a sheet or blanket during sexual activity…               
    
7.  I am comfortable with my partner  
 looking at my genitals during sexual 
 activity……………………………..           
     
8.  During sexual activity I worry that my  
  partner will find my body repulsive……              
      
9.  During sexual activity I worry that my   
  partner will think the size and shape of my  
     sex organs are in-adequate or unattractive           
     
  
 
56  
           
Appendix H:  Body Exposure in Sexual Activities Questionnaire (Continued) 
 
        Never    Rarely   Sometimes  Often      Always 
10.  When it comes to my partner seeing me  
 naked, I have nothing to hide…………           
       
11.  During sexual activity I have thoughts  
     that my body looks sexy……           
        
12.  I don’t like my partner to see me  
  completely naked during sexual activity…              
       
13.  During sexual activity I expect my  
  partner to be excited by seeing me   
  without my clothes……………………                    
 
14.  I prefer to keep certain articles of clothing  
  on during sexual activity………………                    
       
15.  I am self-conscious about my body during  
  sexual activity…………………………….                
                                                                    
16.  During sexual activity I worry that my  
 partner will find the appearance or odor of  
 my genitals repulsive …..           
  
17.  During sexual activity I try to hide certain  
   areas of my body from my partner’s view…          
     
18.  During sexual activity I keep thinking  
   that parts of my body are too 
      unattractive to be sexy………………….           
    
19.  There are parts of my body that I don’t  
 want my partner to see during sexual 
 activity………………………           
    
20.  During sexual activity I worry about  
 what my partner thinks about how my 
 body looks……………………..           
     
21.  During sexual activity I worry that my   
  partner could be turned off by the way  
  parts of my body feel to his/her touch…              
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Appendix H:  Body Exposure in Sexual Activities Questionnaire (Continued) 
       
                                                 Never    Rarely   Sometimes  Often  Always 
22.  During sexual activity it is hard for me  
      not to think about my weight……           
    
    
23.  I feel self-conscious if the room is  
     too well lit during sexual activity           
      
24.  I am generally comfortable having  
     parts of my body exposed to my\ 
    partner during sexual activity…………….           
   
25.  During sexual activity I enjoy having  
  my partner look at my body……………           
       
26.  During sexual activity there are certain  
 poses or positions I avoid because of  
 the way my body would look to my 
 partner …           
      
27.  During sexual activity I am distracted  
  by thoughts of how certain parts of my 
  body look………………………..                 
 
 28.  I am comfortable with my partner  
looking at my breast area during sexual 
activity…….……………………………                 
 
 29.   During sexual activity I worry that my  
  partner will find my breast area repulsive                
 
30.   During sexual activity I worry that my  
 partner will think the size and shape of  
 my breasts are inadequate or unattractive                 
 
 31.  During sexual activity I worry about what  
  my partner thinks about how my breast  
 area looks………………….                     
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 Appendix I:  The Body-Self Relations Questionnaire:  Appearance Evaluation Subscale 
 
Using the scale below, please check one box that best matches your agreement with the 
following statements. 
 
  Definitely 
Disagree 
Mostly 
Disagree
Neither 
Agree nor 
Disagree 
Mostly 
Agree 
Definitely 
Agree 
1. My body is sexually 
appealing……….. 
 
  
 
  
 
  
 
  
 
  
2. I like my looks just  
the way they are…. 
 
  
 
  
 
  
 
  
 
  
3. Most people would  
consider me good 
looking…………… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
4. I like the way I look  
Without my clothes 
 
  
 
  
 
  
 
  
 
  
5. I like the way my  
clothes fit me………. 
 
  
 
  
 
  
 
  
 
  
6. I dislike my 
physique… 
 
  
 
  
 
  
 
  
 
  
7. I’m physically 
unattractive.… 
 
  
 
  
 
  
 
  
 
  
 
 
 
 
 
 
 
 
 
 
Would you be interested in receiving a free copy of the American Cancer Society booklet 
entitled, “Sexuality and Cancer: For the Woman Who Has Cancer, and  
Her Partner”? 
 
    Yes      No 
  
59  
 Appendix J:  Dyadic Adjustment Scale 
 
Most persons have disagreements in their relationships.  Please indicate below the approximate extent of 
agreement or disagreement between you and your partner for  
each item on the following list. 
 
 
Always 
Agree 
Almost 
Always  
Agree 
 
Occasion- 
ally 
Disagree 
 
Frequently 
Disagree 
Almost 
Always 
Disagree 
 
Always 
Disagree 
1.  Demonstrations  
of affection 
 
  
 
  
 
  
 
  
 
  
 
  
 
2.  Sex relations 
 
  
 
  
 
  
 
  
 
  
 
  
 
 
 
 
All 
the time 
 
Most of 
the time 
More 
often 
than not 
 
 
Occasion- 
ally 
 
 
Rarely 
 
 
Never 
  
3. How often do 
you discuss or have 
you considered 
divorce, separation, 
or terminating  
your relationship? 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
  
4.  How often do 
you or your mate 
leave the house after  
a fight? 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
  
5.  In general, how  
often do you think  
that things between 
you and your partner  
are going well? 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
6. Do you confide in  
your mate?……… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
  
7. Do you everregret  
that you married?   
(or lived together). 
 
 
  
 
  
 
  
 
  
 
  
 
  
 8. How often do 
you and your 
partner quarrel? 
 
  
 
  
 
  
 
  
 
  
 
  
  
9. How often do you 
and your mate 
“get on each 
other’s nerves?” 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
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 Appendix J:  Dyadic Adjustment Scale (Continued) 
 
 
 
 
Every Day 
Almost 
Every Day 
 
Occasionally 
 
Rarely 
 
Never 
10. Do you kiss your  
mate?…...           
There are some things about which couples sometimes agree and sometime disagree.   
Indicate if either item below caused differences of opinions or were problems in your 
relationship during the past few weeks.  (Mark an “X” in the box.) 
  
Yes 
 
No 
 
 
11.  Being too tired for sex  
 
  
 
  
 
12.  Not showing love 
 
  
 
  
 
13. The descriptors on the following line represent different degrees of happiness in your 
relationship.  The middle point, “happy,” represents the degree of happiness of most 
relationships.  Please circle the descriptor that best describes the degree of happiness, all 
things considered, of your relationship. 
 
Extremely 
Unhappy 
Fairly 
Unhappy 
A Little 
Unhappy 
Happy Very 
Happy 
Extremely 
Happy 
Perfect 
 
 
14. Which of the following statements best describes how you feel about the future of 
your relationship? (Check one box.) 
 
  I want desperately for my relationship to succeed, and would go to almost any 
length to see that it does. 
 
  I want very much for my relationship to succeed, and will do all I can to see that 
it does. 
 
  I want very much for my relationship to succeed, and will do my fair share to see 
that it does. 
 
  It would be nice if my relationship succeeded, but I can’t do much more than I am 
doing now to help it succeed. 
 
  It would be nice if it succeeded, but I refuse to do any more than I am doing now 
to keep the relationship going. 
 
  My relationship can never succeed, and there is no more that I can do to keep the 
relationship going. 
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 Appendix K:  The Breast Cancer Prevention Trial Symptom Checklist 
 
We are interested in knowing whether you have had any of the following problems 
during the PAST FOUR WEEKS. 
   
Not at 
all 
 
Slightly 
 
Moderately 
 
Quite a bit 
 
Extremely 
1. 
 
Hot flashes……… 
 
  
 
  
 
  
 
  
 
  
 
2. 
 
Headaches……… 
 
  
 
  
 
  
 
  
 
  
 
3. 
 
Blind spots, fuzzy 
vision…………... 
 
  
 
  
 
  
 
  
 
  
 
4. 
 
Nausea…………… 
 
  
 
  
 
  
 
  
 
  
 
5. 
 
Vomiting…………. 
 
  
 
  
 
  
 
  
 
  
 
6. 
 
Diarrhea…………. 
 
  
 
  
 
  
 
  
 
  
 
7. 
 
Constipation……… 
 
  
 
  
 
  
 
  
 
  
 
8. 
 
Difficulty with bladder 
control (when laughing 
or crying)…………. 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
9. 
 
Difficulty with bladder 
control (at other 
times)…………… 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
10. 
 
Vaginal discharge…… 
 
  
 
  
 
  
 
  
 
  
 
11. 
 
Vaginal bleeding or 
spotting……… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
12. 
 
Genital 
itching/irritation… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
13. 
 
Vaginal dryness…… 
 
  
 
  
 
  
 
  
 
  
 
14. 
 
Pain with 
intercourse…………… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
15. 
 
Cramps………………… 
 
  
 
  
 
  
 
  
 
  
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 Appendix K:  The Breast Cancer Prevention Trial Symptom Checklist (Continued) 
 
   
Not at 
all 
 
Slightly 
 
Moderately 
 
Quite a bit 
 
Extremely 
 
16. 
 
Breast 
sensitivity/tenderness… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
17. 
 
Ringing in ears………… 
 
  
 
  
 
  
 
  
 
  
 
18. 
 
General aches and pains.. 
 
  
 
  
 
  
 
  
 
  
 
19. 
 
Joint pains………………
 
  
 
  
 
  
 
  
 
  
 
20. 
 
Chest pains…………… 
 
  
 
  
 
  
 
  
 
  
 
21. 
 
Swelling of hands or 
feet.. 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
  Not at 
all 
 
Slightly 
 
Moderately 
 
Quite a bit 
 
Extremely 
 
22. 
 
Muscle stiffness……… 
 
  
 
  
 
  
 
  
 
  
 
23. 
 
Difficulty breathing…… 
 
  
 
  
 
  
 
  
 
  
 
24. 
 
Dry mouth…………… 
 
  
 
  
 
  
 
  
 
  
 
25. 
 
Weight gain…………… 
 
  
 
  
 
  
 
  
 
  
 
26. 
 
Weight loss…………… 
 
  
 
  
 
  
 
  
 
  
 
27. 
 
Unhappy with the 
appearance of my body.. 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
28. 
 
Decreased appetite…… 
 
  
 
  
 
  
 
  
 
  
 
29. 
 
Feelings of suffocation… 
 
  
 
  
 
  
 
  
 
  
 
30. 
 
Forgetfulness………… 
 
  
 
  
 
  
 
  
 
  
 
31. 
 
Excitability…………… 
 
  
 
  
 
  
 
  
 
  
 
32. 
 
Short temper…………… 
 
  
 
  
 
  
 
  
 
  
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 Appendix K:  The Breast Cancer Prevention Trial Symptom Checklist (Continued) 
 
   
Not at 
all 
 
Slightly 
 
Moderately 
 
Quite a bit 
 
Extremely 
 
33. 
 
Tendency to take naps; 
stay in bed………………
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
34. 
 
Night sweats…………… 
 
  
 
  
 
  
 
  
 
  
 
35. 
 
Cold sweats…………… 
 
  
 
  
 
  
 
  
 
  
 
36. 
 
Tendency toward 
accidents………. 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
37. 
 
Avoidance of social 
affairs……….. 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
38. 
 
Difficulty concentrating.. 
 
  
 
  
 
  
 
  
 
  
 
39. 
 
Easily distracted……… 
 
  
 
  
 
  
 
  
 
  
 
40. 
 
Dizziness, faintness…… 
 
  
 
  
 
  
 
  
 
  
 
41. 
 
Numbness, tingling…… 
 
  
 
  
 
  
 
  
 
  
 
42. 
 
Early awakening……… 
 
  
 
  
 
  
 
  
 
  
 
43. 
 
Any other problems?  
(Please specify.)_______ 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
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 Appendix L:  Sexual Functioning Questionnaire 
 
These next questions are sensitive and personal.  They are very important in understanding 
how your medical illness or treatment affects your self and your body.  Some questions ask 
about your own experiences, thoughts, and feelings, while others ask about how treatment 
has affected your intimate relationships.  Please answer each question honestly and 
accurately.  Be assured that your responses are totally confidential. 
 
1. In the PAST MONTH, how frequently have you had sexual thoughts, urges, 
fantasies, or   erotic dreams?  (Please make an “X” in the one box that is closest to your 
experience.) 
  
    Not at all 
    Once 
    2 or 3 times 
    Once a week 
    2 or 3 times per week 
  Once a day 
  More than once a day 
 
2. Using the scale below, how frequently have you felt an interest or desire to engage in 
the following specific activities in the PAST MONTH?  (This question is about your 
interest and desires, not about how often you have engaged in sexual activity.  For each 
item, please make an “X” in the one box that is closest to your experience): 
 
b 
 
Masturbation 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
c 
 
Touching, 
hugging, holding, 
kissing 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
d 
 
Petting and 
foreplay 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
e 
 
Vaginal 
intercourse 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
f 
 
Other sexual 
activity please 
specify: 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
   
Not  
at  
all 
 
 
 
Once 
 
 
2 to 3 
times 
 
Once 
 a 
week 
 
2 to 3 
times 
per wk
Once 
a 
Day 
More 
than 
once 
a day 
 
a 
 
Dreams or fantasy 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
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 Appendix L:  Sexual Functioning Questionnaire (Continued) 
 
 
3. Using the scale below, how frequently have you become aroused by the following 
sexual activity in the PAST MONTH?  (By arousal, we mean the physical and 
emotional responses in your body and mind that tell you that you are feeling sexual. 
This question is about your arousal, not about how often you have engaged in sexual 
activity): 
 
b 
 
Masturbation 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
c 
 
Touching, hugging, 
holding, kissing 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
d 
 
Petting and 
foreplay 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
e 
 
Vaginal 
intercourse. 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
f 
 
Other sexual 
activity please 
specify: 
________________ 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
   
 
 
Not 
at  
all 
 
 
 
 
 
Once 
 
 
2  
to 
 3 
times 
 
 
 
Once  
a 
week 
2 
to 
 3 
times 
per  
week 
 
 
 
Once 
a 
day 
 
 
More 
than  
once 
a day 
 
a 
 
Dreams or fantasy 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
4. In the PAST MONTH, have you felt pleasure from any sexual activity? (Please mark 
one box.) 
  
     1  I have had no sexual activity in the past month 
     2  I have not felt any pleasure 
     3  Seldom, less than 25% of the time 
     4  Sometimes, about 50% of the time 
     5  Usually, about 75% of the time 
    6  Always felt pleasure 
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 Appendix L:  Sexual Functioning Questionnaire (Continued) 
 
5.  Using the scale below, how frequently have you engaged in the following sexual 
activity in the PAST MONTH? 
 
b 
 
Masturbation 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
c 
 
Touching, hugging, 
holding, kissing 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
d 
 
Petting and 
foreplay 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
e 
 
Vaginal 
intercourse. 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
f 
 
Other sexual 
activity please 
specify: 
________________ 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
   
 
 
 
Not at 
all 
 
 
 
 
 
Once 
 
 
 
 
2 to 3 
times 
 
 
 
 
Once a
week 
2 
to 
 3 
times 
per 
week 
 
 
 
Once  
a 
day 
 
 
More 
than 
 once 
a day 
 
a 
 
Dreams or fantasy 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
6. In the PAST MONTH, how often have you reached orgasm (climax) during sexual 
activity?  (Please mark one box.) 
  
       1  I have had no sexual activity in the past month 
       2  I have not experienced orgasm 
       3  Seldom, less than 25% of the time 
       4  Sometimes, about 50% of the time 
       5  Usually, about 75% of the time 
       6  I always experienced orgasm 
 
7.  When you have orgasms (climax), how intense have they been in the PAST MONTH?     
 
      1  I have had no sexual activity in the past month 
      2  I have had no orgasms in the last month 
      3  My orgasms were very mild 
      4  My orgasms were fairly mild 
      5  My orgasms were fairly strong 
      6  My orgasms were very strong 
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 8. How easy or difficult has it been for you to have orgasms (climax) in the PAST 
MONTH? 
 
      1  I have had no sexual activity in the past month 
      2  I have had no orgasms in the last month 
    3  It was very difficult to have orgasms; it took a long time and a lot of     
concentration 
      4  It was fairly difficult; it took a while 
      5  It was fairly easy 
      6  It was very easy 
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How frequently in the PAST MONTH have you had the problems listed below?                  If you have checked anything other than “not at 
all”,                                                                                                                                                       has it stopped or reduced your sexual 
activity? 
  
c. Problems with touching, hugging, holding, 
kissing………………………………………… 
 
  
 
  
 
  
 
  
 
  ……………  
 
 
  
 
d. Problems with petting and 
foreplay…………………….…………………. 
 
  
 
  
 
  
 
  
 
  
 
……………  
 
  
 
e. 
 
Problems with vaginal 
intercourse…………………………………… 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
……………  
 
 
  
 
f. 
 
Problems with other sexual activity  
Please specify: _________________ 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
……………  
 
 
  
 
g. 
 
 
Vaginal bleeding or irritation after penetration 
or intercourse………………….. 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
……………  
 
 
  
 
h. 
 
Sharp pain inside or outside your vagina… 
 
  
 
  
 
  
 
  
 
  
 
 
……………  
 
  
 
i. Increased sensitivity of your skin to intimate 
touching……………………………. 
 
  
 
  
 
  
 
  
 
  
 
……………  
 
  
 
j. Other problem with sexuality 
Please specify: _________________ 
 
  
 
  
 
  
 
  
 
  
 
……………  
 
  
 
 
 
 
Not at all 
less than 
25% of the 
time 
Some imes 
Less than 
50% of the 
time 
Usually, 
about 75% 
of the time 
 
 
Always 
 
 
 
Yes 
 
 
No 
a. 
 
b. 
Problems with dreams or fantasies……….. 
 
Problems with masturbation……………… 
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
……………  
 
……………  
  
 
  
 
          Seldom, t   
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10. Please rate how interested you have been in sexual thoughts, feelings, or actions in the PAST 
MONTH by circling a number from 0 to 10. 
 
 
  0    1   2  3  4 5 6  7 8 9   10  
Not at all                          Extremely  
Interested                                                                                            Interested                       
 
 
11. Please rate the extent to which sexual activity has been satisfying for you in the PAST 
MONTH by circling a number from 0 to 10. 
 
  0    1   2  3  4 5 6  7 8 9   10  
Not at all                          Extremely  
   Interested                                                                                            Interested        
 
 
12. How often did the following factors influence your sexual activity in the PAST MONTH? 
 
 
b 
 
My partner’s health 
 
  
 
  
 
  
 
  
 
  
 
c 
 
Conflict in my relationship 
 
  
 
  
 
  
 
  
 
  
 
d 
 
Other please specify: 
_____________________ 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
   
 
Not 
at  
all 
Seldom, 
less 
than 25% 
of the 
time 
Sometimes, 
about  
50%  
of 
 the time 
Usually, 
about  
75%  
of  
the time 
 
 
 
 
Always 
 
a 
 
My own health 
 
  
 
  
 
  
 
  
 
  
 
 
13. How frequently have you been able to communicate your sexual desires or preferences to your 
partner in the PAST MONTH? 
 
      1  I have not had a partner 
      2  I was always able to communicate my desires or preferences 
      3  Usually, about 75% of the time 
      4  Sometimes, about 50% of the time 
      5  Seldom, less than 25% of the time 
      6  I have been unable to communicate my desires or preferences 
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14. Overall, how satisfied have you been with your sexual relationship with your partner? 
 
      1  Very satisfied 
      2  Somewhat satisfied 
      3  Neither satisfied nor dissatisfied 
      4  Somewhat dissatisfied 
      5  Very dissatisfied 
 
 
15. Overall, how satisfied do you think your partner has been with your sexual 
relationship? 
 
     1  Very satisfied 
     2  Somewhat satisfied 
     3  Neither satisfied nor dissatisfied 
     4  Somewhat dissatisfied 
     5  Very dissatisfied 
 
 
16. Please rate how satisfied you have been with your ability to share warmth and 
intimacy with your partner in the PAST MONTH by circling the number below from 0 
to 10. 
 
  0    1   2  3  4 5 6  7 8 9   10  
Not at all                          Extremely  
        Satisfied                                                                                                     Satisfied       
 
 
 
17. Please rate how comfortable you are with touching, hugging or holding your 
partner in the PAST MONTH by circling the number below from 0 to 10. 
 
  0    1   2  3  4 5 6  7 8 9   10  
Not at all                          Extremely  
        Comfortable                                                                                              Comfortable       
 
 
 
18. Please rate how well you think you have adjusted to changes in your sex life since 
your breast cancer diagnosis by circling a number from 0 to 10. 
 
 
  0    1   2  3  4 5 6  7 8 9   10  
Not at all                          Extremely  
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 19. What impact has your breast cancer and its treatment had on your sex life? 
 
      1  My sex life is a lot better than before 
      2  My sex life is a little better than before 
      3  My sex life is no different than before 
      4  My sex life is a little worse than before 
      5  My sex life is a lot worse than before 
 
20. What impact has your breast cancer and its treatment had on your interest or desire 
for sex? (This question is about your thoughts, fantasies or wishes, not about how you 
feel during sexual activity.) 
 
 
      1  My interest is stronger 
      2  My interest is about the same 
      3  My interest is a little less 
      4  My interest is somewhat less 
      5  My interest is a lot less 
      6  I have lost all of my interest 
 
 
 
21. What impact has your breast cancer and its treatment had on your sexual arousal 
during sexual activity?  (By arousal, we mean the physical and emotional responses 
in your body and mind that tell you that you are feeling sexual.) 
 
 
      1  I am aroused more easily than ever 
      2  Arousal is about the same 
      3  It takes longer to get aroused, but the level of arousal is about the same 
      4  It takes longer to get aroused, and the level of arousal is not as intense 
      5  It is quite a bit more difficult for me to get aroused 
      6  I do not seem able to get aroused al all  
 
 
72  
 73  
Appendix L:  Sexual Functioning Questionnaire (Continued) 
 
22. What impact has your breast cancer and its treatment had on your orgasms during 
sex? 
 
 
      1  They are stronger than ever 
      2  They are about the same 
    3  It takes longer to get orgasm, but the intensity is about the same 
      4  It takes longer to get orgasm, and they are less intense than before the 
illness and treatment 
      5  Since the treatment, I am unable to orgasm 
      6  I have never experienced orgasm 
 
 
 
23. Is there anything you would like to add about how sex has changed for you since 
your breast cancer and its treatment?  Please describe below, as well as on the back 
of this sheet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
